Tanveer, M., & Ahsan Kamal. (2026). FDAs new approval: yeztugo (lenacapavir): a longer lasting avenue against HIV. Journal of the Pakistan Medical Association, 76(8), 1401–1401. https://doi.org/10.47391/JPMA.33073